Exercise Performance and Dynamic Hyperinflation in Lymphangioleiomyomatosis

Imagem de Miniatura
Arquivos
art_BALDI_Exercise_Performance_and_Dynamic_Hyperinflation_in_Lymphangioleiomyomatosis_2012_eng.pdf (512 KB)
Citações na Scopus
29
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER THORACIC SOC
Autores
Citação
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, v.186, n.4, p.341-348, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Rationale: Lymphangioleiomyomatosis (LAM) is characterized by exercise performance impairment. Although airflow limitation is common, no previous studies have evaluated the prevalence and impact of dynamic hyperinflation (DH) in LAM. Objectives: To investigate the dynamic responses during maximal exercise and the prevalence, predictors, and repercussions of DH in LAM. Methods: Forty-two patients with LAM performed symptom-limited incremental cycle exercise and pulmonary functions tests (PFTs) and were compared with 10 age-matched healthy women. Dyspnea intensity, inspiratory capacity, oxygen saturation, and cardiac, metabolic, and respiratory variables were assessed during exercise. Patients with LAM also performed a 6-minute walk test (6MWT). Measurements and Main Results: Patients with LAM had higher baseline dyspnea, poorer quality of life, obstructive pattern, air trapping, and reduced diffusing capacity of carbon monoxide in PFTs. Although they had the same level of regular physical activity, their maximal exercise performance was reduced and was associated with ventilatory limitation, greater desaturation, and dyspnea. The prevalence of DH was high in LAM (55%), even in patients with mild spirometric abnormalities, and was correlated with airflow obstruction, air trapping, and diffusing capacity of carbon monoxide. Compared with the non-DH subgroup, the patients who developed DH had a ventilatory limitation contributing to exercise cessation on cycling and higher desaturation and dyspnea intensity during the 6MWT. Conclusions: Ventilatory limitation and gas exchange impairment are important causes of exercise limitation in LAM. DH is frequent in LAM, even in patients with mild spirometric abnormalities. DH was associated with the severity of disease, higher dyspnea, and lower oxygen saturation. In the 6MWT, desaturation and dyspnea were greater in patients with DH.
Palavras-chave
lymphangioleiomyomatosis, obstructive lung disease, pulmonary function tests, exercise test
URI
https://observatorio.fm.usp.br/handle/OPI/218
Referências
  1. Baldi BG, 2011, CLINICS, V66, P1301, DOI 10.1590/S1807-59322011000700031
  2. Baldi BG, 2010, AM J RESP CRIT CARE, V181, pA5988
  3. BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
  4. Calverley PMA, 2005, EUR RESPIR J, V25, P186, DOI 10.1183/09031936.04.00113204
  5. Casaburi Richard, 2006, Proc Am Thorac Soc, V3, P185, DOI 10.1513/pats.200508-095DO
  6. Chiappa GR, 2009, AM J RESP CRIT CARE, V179, P1004, DOI 10.1164/rccm.200811-1793OC
  7. Chu SC, 1999, CHEST, V115, P1041, DOI 10.1378/chest.115.4.1041
  8. Ciconelli PM, 1999, REV BRAS REUMATOL, V39, P143
  9. Crausman RS, 1996, AM J RESP CRIT CARE, V153, P1368
  10. Glassberg MK, 2004, CLIN CHEST MED, V25, P573, DOI 10.1016/j.ccm.2004.05.003
  11. Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1249/mss.0b013e3180616b27
  12. Hayashi T, 1997, HUM PATHOL, V28, P1071, DOI 10.1016/S0046-8177(97)90061-7
  13. Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209
  14. MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905
  15. MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751
  16. Matsui K, 2000, ARCH PATHOL LAB MED, V124, P267
  17. Medeiros P, 2012, RESP MED, V106, P420, DOI 10.1016/j.rmed.2011.12.008
  18. Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
  19. Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703
  20. Neder JA, 1999, EUR RESPIR J, V14, P1304, DOI 10.1183/09031936.99.14613049
  21. Neder JA, 1999, BRAZ J MED BIOL RES, V32, P729
  22. O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770
  23. O'Donnell DE, 2004, EUR RESPIR J, V24, P86, DOI 10.1183/09031936.04.00072703
  24. O'Donnell DE, 2004, EUR RESPIR J, V23, P832, DOI 10.1183/09031936.04.00116004
  25. O'Donnell DE, 2009, EUR RESPIR J, V34, P866, DOI 10.1183/09031936.00168708
  26. Pereira Carlos Alberto de Castro, 2007, J Bras Pneumol, V33, P397
  27. Pollock-Barziv SM, 2005, RESP MED, V99, P901, DOI 10.1016/j.rmed.2004.12.005
  28. Porszasz J, 2005, CHEST, V128, P2025, DOI 10.1378/chest.128.4.2025
  29. Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC
  30. Soares MR, 2011, J BRAS PNEUMOL, V37, P576
  31. Somfay A, 2001, EUR RESPIR J, V18, P77, DOI 10.1183/09031936.01.00082201
  32. STUBBING DG, 1980, J APPL PHYSIOL, V49, P511
  33. Taveira da Silva AM, 2006, CANC CONTR, V13, P276
  34. Taveira-DaSilva AM, 2003, AM J RESP CRIT CARE, V168, P1427, DOI 10.1164/rccm.200203-593OC
  35. Taveira-DaSilva AM, 2007, CHEST, V132, P1573, DOI 10.1378/chest.07-1205
  36. Taveira-DaSilva AM, 2001, AM J RESP CRIT CARE, V164, P1072
  37. Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005
  38. Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008
  39. Yan S, 1997, AM J RESP CRIT CARE, V156, P55
  40. Zhe XN, 2003, AM J RESP CELL MOL, V28, P504, DOI 10.1165/rcmb.2002-0124OC
  41. Zimmermann CS, 2007, BRAZ J MED BIOL RES, V40, P179, DOI 10.1590/S0100-879X2006005000056
  42. [Anonymous], 2002, AM J RESP CRIT CARE, V166, P111

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/09